uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Surface modification of primary human hepatocytes with recombinant CD39 protects against thromboinfiammation
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology, Clinical Immunology.
Show others and affiliations
2015 (English)In: Molecular Immunology, ISSN 0161-5890, E-ISSN 1872-9142, Vol. 67, no 1, 149-150 p.Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
2015. Vol. 67, no 1, 149-150 p.
National Category
Immunology in the medical area
Identifiers
URN: urn:nbn:se:uu:diva-261045ISI: 000357144100102OAI: oai:DiVA.org:uu-261045DiVA: diva2:850335
Conference
15th European Meeting on Complement in Human Disease (EMCHD), JUN 27-30, 2015, Uppsala, SWEDEN
Available from: 2015-09-01 Created: 2015-08-28 Last updated: 2017-12-04Bibliographically approved

Open Access in DiVA

No full text

Authority records BETA

Asif, SanaEkdahl, Kristina NilssonNilsson, Bo

Search in DiVA

By author/editor
Asif, SanaEkdahl, Kristina NilssonNilsson, Bo
By organisation
Clinical Immunology
In the same journal
Molecular Immunology
Immunology in the medical area

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 592 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf